Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,073 | -6,233 | -26,089 | -18,501 | -13,022 |
| Depreciation Amortization | 16 | 9 | 54 | 43 | 30 |
| Accounts payable and accrued liabilities | -358 | -270 | 106 | -249 | 342 |
| Other Working Capital | -2,034 | -2,723 | 437 | 52 | -72 |
| Other Operating Activity | 1,094 | 575 | 1,521 | 1,508 | 466 |
| Operating Cash Flow | $-13,355 | $-8,642 | $-23,971 | $-17,147 | $-12,256 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -7 | -6 | -7 | -4 |
| Investing Cash Flow | $-10 | $-7 | $-6 | $-7 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 490 | 73 | 12,714 | 6,352 | N/A |
| Other Financing Activity | 0 | 0 | 10,825 | 0 | 3,462 |
| Financing Cash Flow | $490 | $73 | $23,539 | $6,352 | $3,462 |
| Exchange Rate Effect | -9 | -10 | -13 | -10 | -19 |
| Beginning Cash Position | 25,134 | 25,134 | 25,585 | 25,585 | 25,585 |
| End Cash Position | 12,250 | 16,548 | 25,134 | 14,773 | 16,768 |
| Net Cash Flow | $-12,884 | $-8,586 | $-451 | $-10,812 | $-8,817 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,355 | -8,642 | -23,971 | -17,147 | -12,256 |
| Capital Expenditure | -10 | -7 | -6 | -7 | -4 |
| Free Cash Flow | -13,365 | -8,649 | -23,977 | -17,154 | -12,260 |